BMJ Paediatrics Open (Aug 2024)

Clinical features, biomarkers and diabetic ketoacidosis at diagnosis of type 1 diabetes among children and adolescents in Sana’a, Yemen

  • Abdallah Ahmed Gunaid,
  • Ahmed Nasser Al-Radaei,
  • Graham D Ogle,
  • Farouk Abdulrahman Al-Qadasi,
  • Jayanthi Maniam,
  • Hadeel Radwan El-Shoubaki

DOI
https://doi.org/10.1136/bmjpo-2024-002680
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

Introduction There is little published information on type 1 diabetes (T1D) in children in Yemen. We aimed to identify the clinical characteristics, biomarkers and diabetic ketoacidosis (DKA) at diagnosis of T1D among children and adolescents in a diabetes centre in Sana’a, Yemen.Methods A total of 485 children and adolescents aged ≤18 years diagnosed with T1D during the period 2010–2020 were included in the study. The variables investigated were demographic and clinical characteristics, biomarkers, subtypes of T1D, and the risk factors for severe DKA at diagnosis.Results At diagnosis, children aged <10 years compared with those aged ≥10 years had higher mean plasma glucose (p<0.001) and mean HbA1c (p=0.026), and lower mean C-peptide (pmol/L) (p=0.019), and a higher frequency of DKA at diagnosis than older children (p<0.001). A majority of the study population (383, 79%) presented in DKA . Children aged <10 years presenting with DKA had significantly longer median appraisal interval (p=0.009) and median total diagnosis interval (p=0.025), and significantly lower mean C-peptide (p=0.001) as compared with their peers without DKA. The prevalence of autoantibody-negative ‘idiopathic’ T1D was 36 (32%) of the total number tested for autoantibody and familial T1D 61 (12.6%) of all the study population.Conclusion In Yemen children aged <10 years with new-onset T1D frequently faced the challenge of a delay in diagnosis and treatment initiation, with severe hyperglycaemia and a higher risk of DKA at diagnosis.